VORJA MIEL 5 mg/1 mg, lozenge tablet sweetened with sorbitol and with stévia 24 tablets
Active ingredients: Chlorhexidine, Lidocaine hydrochloride, Chlorhexidine dihydrochloride, Lidocaine
Commercialized according to BDPM
Lozenge tablet24 tabletsvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VORJA MIEL 5 mg/1 mg, comprimé à sucer édulcoré au sorbitol et à la stévia
- Pharmaceutical form
- comprimé à sucer
- Route of administration
- voie buccale autre
- Presentation description
- 24 plaquette(s) aluminium PVC polyéthylène PVDC de 1 comprimé(s)
- Marketing authorisation holder
- LABORATOIRE VICKS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jul 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60211272CIP73031609CIP133400930316092Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEcomprimé | 0,81 mg · un comprimé | FT |
| CHLORHYDRATE DE LIDOCAÏNE MONOHYDRATÉcomprimé | 1 mg · un comprimé | SA |
| CHLORHEXIDINEcomprimé | 4,37 mg · un comprimé | FT |
| DICHLORHYDRATE DE CHLORHEXIDINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.